The value of Tc-99m tetrofosmin thyroid scintigraphy in patients with nodular goiter

[1]  M. Salvatore,et al.  Technetium-99m-tetrofosmin imaging of differentiated mixed thyroid cancer. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  M. Kaplan,et al.  Advances in the management of patients with thyroid disease. , 1995, Seminars in nuclear medicine.

[3]  J. Mattera,et al.  Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  E. Mazzaferri,et al.  Management of a solitary thyroid nodule. , 1993, The New England journal of medicine.

[5]  F. Smith,et al.  Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  L. Kivisaari,et al.  Clinical versus ultrasound examination of the thyroid gland in common clinical practice , 1992, Journal of clinical ultrasound : JCU.

[7]  J. Hamming,et al.  The value of fine-needle aspiration biopsy in patients with nodular thyroid disease divided into groups of suspicion of malignant neoplasms on clinical grounds. , 1990, Archives of internal medicine.

[8]  H. Gharib,et al.  Nodular thyroid disease. Evaluation and management. , 1985, The New England journal of medicine.